Allworth Financial LP Rallybio Corp Transaction History
Allworth Financial LP
- $20.2 Billion
- Q2 2025
A detailed history of Allworth Financial LP transactions in Rallybio Corp stock. As of the latest transaction made, Allworth Financial LP holds 50 shares of RLYB stock, worth $32. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50Holding current value
$32% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RLYB
# of Institutions
49Shares Held
31.1MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$2.68 Million0.0% of portfolio
-
Johnson & Johnson New Brunswick, NJ3.64MShares$2.33 Million0.42% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$2.32 Million0.83% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$2.11 Million3.34% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$1.94 Million0.06% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $20.6M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...